Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations
Xuan Zheng(Jinan University), Xiaoyun Lu(Jinan University)
Cited by 6
Related Papers
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
|Frontiers in Oncology|2021|125
Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach
|Antimicrobial Agents and Chemotherapy|2019|27
<p>Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma</p>
|Cancer Management and Research|2020|11
Identification and Analysis of Genes Involved in Double Fertilization in Rice
|International Journal of Molecular Sciences|2021|9